Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis
作者: Vanessa L. KronzerCynthia S. CrowsonJeffrey A. SparksElena MyasoedovaJohn M. Davis
作者单位: 1Division of Rheumatology, Mayo Clinic, Rochester, MN
2Department of Health Sciences Research, Mayo Clinic, Rochester, MN
3Division of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, Boston, MA
刊名: Mayo Clinic Proceedings, 2019, Vol.94 (12), pp.2488-2498
来源数据库: Elsevier Journal
DOI: 10.1016/j.mayocp.2019.08.010
英文摘要: Abstract(#br)Objective(#br)To determine the prevalence of comorbidities in rheumatoid arthritis (RA), discover which comorbidities might predispose to developing RA, and identify which comorbidities are more likely to develop after RA.(#br)Patients and Methods(#br)We performed a case-control study using a single-center biobank, identifying 821 cases of RA (143 incident RA) between January 1, 2009, and February 28, 2018, defined as 2 diagnosis codes plus a disease-modifying antirheumatic drug. We matched each case to 3 controls based on age and sex. Participants self-reported the presence and onset of 74 comorbidities. Logistic regression models adjusted for race, body mass index, education, smoking, and Charlson comorbidity index.(#br)Results(#br)After adjustment for confounders and...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:5.79 (2012)

×